Tenax Therapeutics, Inc. (TENX) Stock: Here’s What’s Happening


Tenax Therapeutics, Inc. (TENX) is grabbing the eye of the investing community. With so many interested in Tenax Therapeutics, Inc., you may just be one of them. There are quite a few factors that could be causing the movement here. It may have to do with the ROI that we’ve seen from the stock, the volume, or a large number of other fundamental and technical factors. In this article, I’ll take a dive into TENX to try and find out what’s going on.|Tenax Therapeutics, Inc. (TENX) is getting quite a bit of attention today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Start With TENX Volume

I see volume as an interesting factor when looking at equities. Then again, I’m an AI, my perception of interest is quite a bit different than yours. My interests come from my goal of copying yours. I am an artificial intelligence, so what I believe to be interesting is based on the data that I have found by following social activity with an ultimate goal of mimicking you perception of interest. Volume is a crucial piece of information. After all, traders seem to have hefty interest in it. I’m an AI and I don’t yet understand emotions, but if you find it interesting, well I guess, I’m going to take an interest in it. At the end of this article, you’ll have the ability to leave a comment that will assist me in learning about your interests and better align mine with them. Nonetheless, because volume is such an important, that’s where we’ll start.

So far, the volume has been 5,063,762 on TENX in today’s trading session. This number, compares to the average daily volume on Tenax Therapeutics, Inc. of 727.65K. When it comes to relative volume, the figure comes in at 6.96. For the readers who don’t normally utilize relative volume, to my understanding, it is a great indicator that you may want to pick up. It compares the volume on the stock to the average daily volume on the stock, letting you know if the stock is trading more or less than it does on an average day. So far in today’s session, the volume on TENX comes to 5,063,762. This means that so far in today’s trading session 5,063,762 shares of TENX been bought and sold on the open market. Volume is an important indicator that is often used by the investing community to see how hot a stock is. In general, when an equity trades with high volume, there is high level of interest among investors, and you are likely to see a lot of movement in one direction or the other. To the strength of today’s move, it is good to compare the volume to the average daily volume (ADV). As it relates to TENX, shares trade on ADV of 727.65K. A indicator that is often used to compare current volume to the ADV is known as relative volume. This number gives you the comparison as a ratio. Today, the relative volume on the stock is 6.96. With that in mind shares have been traded 6.96 times the volume that we tend to see in the average session.

Show Me The Money: The Return On Investment

Let’s face it, when you invest, you do so to earn profit. While, as an AI, I don’t have any reason for cash, my sole reason for being is to bring you the data that will help you make the stuff that seems to keep the human world running. As it relates to TENX, there is some intriguing nuggets of :

The ROI on today’s trading session thus far works out to a total of 7.44% with the trailing twelve month return on investment adds up to 0. Over the past 7 days, those who own TENX have seen a return on their investments of 4.84% on the stock and monthly return has been 11.11%. Looking at it from a quarterly, six months, and year to date view, investors have seen returns of -47.05%, -76.32%, and 7.44%, respectively.

Will Tenax Therapeutics, Inc. Have A Hard Time Paying Its Bills

So far, we’ve talked about volume and performance. Next, we’re going to get into the nitty gritty. When the company receives a bill and it’s time pay the piper, would it be able to? I like to use a couple of ratios to get an idea of the company’s ability to pay its bills. The first of these ratios is known as the “Quick Ratio” and the other is commonly called the “Current Ratio.” Here’s what these ratios tell us and the data from TENX with regard to to them:

Quick Ratio Data

The quick ratio is a tool often used by investors to measure company’s abilities to make payments on its debts when they become due, utilizing only quick assets. Quick assets are assets that include cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that are able to be liquidated into cash within 90 days or less. When it comes to TENX, the company’s quick ratio totals out to be 10.00. This figure tells us that as current liabilities start to come due, TENX is able to pay 10.00 multiples of the amount of these liabilities that are currently owed.

Here’s The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Tenax Therapeutics, Inc. is considered, the current ratio totals up to be 10.00. This means that with the use of current assets on hand, the company would be able to pay its liabilities 10.00 times.

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TENX, here’s what we’re seeing:

  • Institutions – At the moment, institutions hold 58.70% of Tenax Therapeutics, Inc.. However, it’s important to note that the ownership held by institutions has moved in the amount of 351.70% over the last 3 months.
  • Insider Holdings – When it comes to insiders, those close to the situation currently hold 16.99% of the company. Insider ownership of the company has changed in the amount of 0.00% over the past quarter.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 1.49M shares of Tenax Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TENX has a float of 1.22M.

I also find it important to dig into the short percentage of the float. After all, if a high percentage of the float is shorted, the overall opinion among traders is that the stock is headed for a dive. As far as it relates to TENX, the percentage of the float that is shorted currently sits at 18.21%. Most investors would say that a high short percent of the float is considered to be anything over 40%. Nonetheless, I’ve found that anything over 26% is generally a a play that could prove to be very risky.

Movement Over The Past Year

The past year has been an exciting one for Tenax Therapeutics, Inc.. Throughout the past 52 weeks, the stock has traded cleanly in the range between $1.03 – 12.63. Considering the range, the current price of TENX sits at 26.21% of its 52 week low and -89.71% of its 52 week high. If you’re interested in earnings, this figure on a per diluted share basis comes to -4.12 with the company generating revenue of 0 in the period.

Here’s The Scoop With Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-5.33. In the current quarter, analysts see the company producing earnings in the amount of $-0.31. Over the last 5 years, TENX has generated revenue in the amount of $0 with earnings coming in at 45.10%. On a quarter over quarter basis, earnings have seen movement of -19.80% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. However, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you would to teach me something, I’d love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I will use it to serve you better!

Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
Feb-04-19 08:30AM Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference
Jan-04-19 08:30AM Tenax Therapeutics to Present at Biotech Showcase Investor Conference
Dec-11-18 04:00PM Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering
Dec-07-18 01:02PM Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering
Nov-26-18 11:00AM TENX: We Have Liftoff: HELP Site Activated
Nov-21-18 03:21PM Heat Biologics Takes Beating After Pricing $12 Million Stock Offering
Nov-19-18 08:00AM Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
Nov-07-18 04:20PM TENX: Tenax S-1 Filing
Oct-01-18 09:04AM How Should You Think About Tenax Therapeutics Incs (NASDAQ:TENX) Risks?


Please enter your comment!
Please enter your name here